Pamela Contreras
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Pamela Contreras has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
- Alfredo Criollo
INSERM, U848, Villejuif, France
13 shared publications - Andrea Maturana-Ramírez
Department of Pathology and Oral Medicine, Faculty of Dentistry, Universidad de Chile, Santiago, Chile
13 shared publications - Andrew Frederick Geoffery Quest
Cellular Communication Laboratory, Center for Studies on Exercise, Metabolism and Cancer (CEMC), Institute of Biomedical Sciences (ICBM), Faculty of Medicine, University of Chile, Santiago, Chile; Advanced Center for Chronic Diseases (ACCDiS), Faculty of Medicine, University of Chile, Santiago, Chile
13 shared publications - Catalina Kretschmar
Department of Ophthalmology, University of California San Francisco, San Francisco, CA, USA
13 shared publications - Daniel Peña-Oyarzún
School of Odontology, Faculty of Odontology, Universidad San Sebastián, Santiago, Chile
13 shared publications - Lorena Lobos-González
Centro de Estudios en Ejercicio, Metabolismo y Cáncer (CEMC), Interdisciplinary Nucleus of Biology and Genetics (NiBG), Instituto de Ciencias Biomédicas (ICBM), University of Chile, Santiago 8370854, Chile
13 shared publications
Latest Publications
- Open Access
- 5 January 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S2 from Inhibition of PORCN Blocks Wnt Signaling to Attenuate Progression of Oral Carcinogenesis
Specificity of C59 over endogenous Wnt3a signaling in DOK-TC cells
- 5 January 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S2 from Inhibition of PORCN Blocks Wnt Signaling to Attenuate Progression of Oral Carcinogenesis
Specificity of C59 over endogenous Wnt3a signaling in DOK-TC cells
- Open Access
- 5 January 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S5 from Inhibition of PORCN Blocks Wnt Signaling to Attenuate Progression of Oral Carcinogenesis
Clinical presentation of human oral lesions used as oral carcinogenesis ex vivo modeL
- 5 January 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S5 from Inhibition of PORCN Blocks Wnt Signaling to Attenuate Progression of Oral Carcinogenesis
Clinical presentation of human oral lesions used as oral carcinogenesis ex vivo modeL
- Open Access
- 5 January 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S4 from Inhibition of PORCN Blocks Wnt Signaling to Attenuate Progression of Oral Carcinogenesis
Effect of C59 on cell invasion in CAL-27 cells
- 5 January 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S4 from Inhibition of PORCN Blocks Wnt Signaling to Attenuate Progression of Oral Carcinogenesis
Effect of C59 on cell invasion in CAL-27 cells
- Open Access
- 5 January 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S1 from Inhibition of PORCN Blocks Wnt Signaling to Attenuate Progression of Oral Carcinogenesis
Characterization of the in vitro human oral carcinogenesis model
- 5 January 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S1 from Inhibition of PORCN Blocks Wnt Signaling to Attenuate Progression of Oral Carcinogenesis
Characterization of the in vitro human oral carcinogenesis model
- Open Access
- 5 January 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S5 from Inhibition of PORCN Blocks Wnt Signaling to Attenuate Progression of Oral Carcinogenesis
Clinical presentation of human oral lesions used as oral carcinogenesis ex vivo modeL
- 5 January 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S5 from Inhibition of PORCN Blocks Wnt Signaling to Attenuate Progression of Oral Carcinogenesis
Clinical presentation of human oral lesions used as oral carcinogenesis ex vivo modeL
- Open Access
- 5 January 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S4 from Inhibition of PORCN Blocks Wnt Signaling to Attenuate Progression of Oral Carcinogenesis
Effect of C59 on cell invasion in CAL-27 cells
- 5 January 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S4 from Inhibition of PORCN Blocks Wnt Signaling to Attenuate Progression of Oral Carcinogenesis
Effect of C59 on cell invasion in CAL-27 cells
- Open Access
- 5 January 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S2 from Inhibition of PORCN Blocks Wnt Signaling to Attenuate Progression of Oral Carcinogenesis
Specificity of C59 over endogenous Wnt3a signaling in DOK-TC cells
- 5 January 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S2 from Inhibition of PORCN Blocks Wnt Signaling to Attenuate Progression of Oral Carcinogenesis
Specificity of C59 over endogenous Wnt3a signaling in DOK-TC cells
- Open Access
- 5 January 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S1 from Inhibition of PORCN Blocks Wnt Signaling to Attenuate Progression of Oral Carcinogenesis
Characterization of the in vitro human oral carcinogenesis model
- 5 January 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S1 from Inhibition of PORCN Blocks Wnt Signaling to Attenuate Progression of Oral Carcinogenesis
Characterization of the in vitro human oral carcinogenesis model